GRASSI, ELISA STELLARIA
 Distribuzione geografica
Continente #
AS - Asia 1.962
NA - Nord America 1.719
EU - Europa 1.659
SA - Sud America 177
AF - Africa 40
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.568
Nazione #
US - Stati Uniti d'America 1.657
CN - Cina 772
SG - Singapore 566
IT - Italia 369
GB - Regno Unito 332
DE - Germania 318
HK - Hong Kong 160
VN - Vietnam 157
BR - Brasile 141
SE - Svezia 134
RU - Federazione Russa 107
IN - India 91
NL - Olanda 85
FR - Francia 61
FI - Finlandia 59
DK - Danimarca 44
CA - Canada 37
JP - Giappone 37
ID - Indonesia 36
KR - Corea 29
IE - Irlanda 28
TR - Turchia 21
BD - Bangladesh 20
ES - Italia 17
UA - Ucraina 16
MX - Messico 14
CH - Svizzera 13
PL - Polonia 13
AR - Argentina 12
PK - Pakistan 12
BE - Belgio 11
AT - Austria 9
AU - Australia 9
CI - Costa d'Avorio 9
EC - Ecuador 9
IR - Iran 8
GR - Grecia 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
PT - Portogallo 6
TH - Thailandia 6
UZ - Uzbekistan 6
AL - Albania 5
CZ - Repubblica Ceca 5
TN - Tunisia 5
ZA - Sudafrica 5
CO - Colombia 4
EG - Egitto 4
IQ - Iraq 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CL - Cile 3
GT - Guatemala 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PY - Paraguay 3
SC - Seychelles 3
VE - Venezuela 3
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
LY - Libia 1
MG - Madagascar 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.568
Città #
Singapore 329
Southend 247
Ashburn 241
Hong Kong 139
Milan 137
Hanover 127
Chandler 121
Shanghai 121
San Jose 114
Fairfield 108
Wilmington 78
Beijing 77
Dallas 72
Hefei 70
Council Bluffs 68
Seattle 61
Frankfurt am Main 55
Los Angeles 55
Ho Chi Minh City 53
Ann Arbor 50
Woodbridge 48
Suzhou 44
Hanoi 43
Helsinki 41
Cambridge 39
Ealing 39
Houston 36
Jakarta 33
Princeton 31
Bengaluru 30
Santa Clara 30
Dublin 28
Tokyo 27
Guangzhou 25
Moscow 25
Lauterbourg 23
Munich 22
Nanjing 21
New York 21
Kent 19
Seoul 19
Chicago 18
Boardman 17
Grafing 17
Bologna 15
Columbus 15
Nuremberg 15
Buffalo 14
Cangzhou 14
The Dalles 14
Naples 13
Phoenix 13
São Paulo 13
Hangzhou 12
Da Nang 11
Des Moines 11
Istanbul 11
Shenzhen 11
Toronto 11
Berlin 10
Brussels 10
Düsseldorf 10
Abidjan 9
Besnate 9
Dearborn 9
Falls Church 9
London 9
Montreal 9
Ottawa 9
Zhengzhou 9
Atlanta 8
Mannheim 8
Rio de Janeiro 8
Shenyang 8
Tehran 8
Wuhan 8
Athens 7
Bernolákovo 7
Central 7
Haiphong 7
Redwood City 7
Warsaw 7
West Drayton 7
Jinan 6
Nanchang 6
Rome 6
Salt Lake City 6
San Diego 6
Tianjin 6
Can Tho 5
Castronno 5
Champaign 5
Fremont 5
Fuzhou 5
Guayaquil 5
Kunshan 5
Lappeenranta 5
Madison 5
Ningbo 5
Orem 5
Totale 3.502
Nome #
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation 660
Thyrotropin receptor p.N432D retained variant is degraded through an alternative lysosomal/autophagosomal pathway and can be functionally rescued by chemical chaperones 316
P53 AND MICROTUBULES TARGETING AS A NOVEL STRATEGY WITH POTENTIAL FOR TREATMENT OF AGGRESSIVE POORLY DIFFERENTIATED THYROID CANCER. 306
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 304
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways 284
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms 265
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas 256
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors 256
Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism 218
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation 213
Tumor and normal thyroid spheroids : from tissues to zebrafish 204
FAM83B is involved in thyroid cancer cell differentiation and migration 181
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies 180
Loss-of-function variants in a Hungarian cohort reveal structural Insights on TSH receptor maturation and signaling 178
8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth 163
Niche-derived soluble DLK1 promotes glioma growth 163
Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma 161
Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance 156
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies 153
Multicellular spheroids: a new model to screen novel drugs for incurable forms of thyroid cancer 131
Three-dimensional multicellular spheroids: an alternative model to screen new drugs for incurable forms of thyroid cancer 126
Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma 119
The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines 119
Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart 115
Three-dimensional spheroids: a new approach for the identification and characterization of novel markers for tumor-initiating cells subpopulations in thyroid cancer 114
The extracellular matrix actively influence thyroid cancer cells sensitivity to TKIS 109
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies 107
Characterization of epcam in thyroid cancer biology by three-dimensional spheroids in vitro model 93
CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells 82
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors 20
Totale 5.752
Categoria #
all - tutte 15.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 23 21
2021/2022523 29 27 23 23 26 23 50 53 86 64 61 58
2022/2023443 54 57 31 46 48 67 10 30 42 17 25 16
2023/2024468 15 23 21 40 73 26 19 24 25 59 54 89
2024/20251.150 77 126 33 97 60 57 57 113 79 146 95 210
2025/20262.094 218 200 219 228 236 185 267 112 178 143 108 0
Totale 5.752